Vitamin D Receptor Agonist Paricalcitol plus Gemcitabine and Nab-paclitaxel in Patients with Metastatic Pancreatic Cancer

NOT ENROLLING
Protocol # :
18-021
Conditions
Pancreatic Cancer
Phase
I/II
Disease Sites
Pancreas
Principal Investigator
Perez, Kimberly
Site Investigator
Constantine, Michael
Hu, Jingjing
Site Research Nurses
Brule, Maurice, N.
Connelly, Alexandra
Fleming, Norah, Michelle
Freeman, Stefani, Danielle
Gentile, Alissa
Germon, Victoria
Graham, Christopher
Hixon, Nicole, R.
Kosinski, Michelle
Piper, Audrey, L.
Sawin, Mark

Trial Description

Call 877-DF-TRIAL (877-338-7425) to learn more about this clinical trial, protocol #18-021

18-021